Core Insights - The modern pharmaceutical industry in Jining has been identified as one of the 15 key industrial chains and 7 key industrial clusters, with a target to exceed 50 billion yuan by 2027 [1] Group 1: Financial Innovation - China Construction Bank's Jining Xicheng Branch has introduced differentiated financial solutions to address the unique challenges faced by pharmaceutical companies, such as high R&D costs and long capital recovery cycles [2][3] - The bank has transformed intangible assets like drug registration certificates and patents into core credit assets, enabling companies to leverage these for financing [2] - A "supply chain finance" service has been launched to improve cash flow for pharmaceutical distribution companies by converting long payment terms into quicker turnover [2] Group 2: Digital Transformation - The bank has optimized service processes by creating an online financing platform that streamlines loan applications, approvals, and disbursements, significantly reducing the time and materials required [3] - Customized financial solutions are provided based on the different stages of pharmaceutical companies, including R&D loans for early-stage firms and fixed asset loans for those in industrialization [3] Group 3: Resource Integration - The bank is actively building a financial ecosystem for the pharmaceutical industry by organizing investment and financing matchmaking events that connect pharmaceutical companies with investors and industry experts [4] - Collaborations with government and industry associations have been established to create risk compensation mechanisms, lowering financing barriers for pharmaceutical companies [4] - Joint efforts with research institutions are aimed at providing technical assessments and facilitating the commercialization of innovations [4] Group 4: Case Study and Impact - A local high-tech pharmaceutical company received a 6 million yuan intellectual property pledge loan, which significantly accelerated its R&D progress and is expected to bring new veterinary drugs to market sooner [5][6] - Over 5 billion yuan in credit support has been provided to more than 20 local pharmaceutical companies, contributing to the industry's development and upgrade [6] - The bank plans to continue enhancing financial services for the pharmaceutical sector, focusing on effective resource allocation and expanding the "supply chain finance + digital" model [6]

Core Viewpoint - The signing of the "Special Agreement for Serving Technological Innovation in Xicheng District" aims to integrate policy guidance and financial services to build a new system for technology finance in Xicheng District [1]. Group 1: Agreement Details - The agreement was signed between Bank of China Beijing Branch and PICC Property and Casualty Company Beijing Branch, witnessed by the Xicheng District People's Government [1]. - The collaboration will establish a new mechanism for "government-bank-insurance" coordinated services, combining policy guidance, financial services, and insurance protection [1]. Group 2: Objectives and Contributions - The initiative is part of Xicheng District's efforts to implement the central government's financial policies and support the capital's development [1]. - The Bank of China will enhance comprehensive financial services for key enterprises in Xicheng, while PICC will provide risk protection and innovative insurance services [1]. - The Xicheng District People's Government will continue to optimize the business environment and provide policy support [2]. Group 3: Future Plans - Xicheng District plans to deepen "government-bank-insurance" cooperation and improve the technology finance service system to inject new momentum into regional economic development [2].